# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA654828 | F | Tested for cytotoxic concentration against human immunodeficiency virus (HIV) in CEM-SS cells | Homo sapiens | 1 | ALA1130554 | cell-based format | Scientific Literature | |
2. | ALA656283 | F | Tested for effective concentration to inhibit human immunodeficiency virus (HIV) in CEM-SS cells | Homo sapiens | 1 | ALA1130554 | cell-based format | Scientific Literature | |
3. | ALA692747 | F | Tested for cytotoxic concentration against human cytomegalovirus (HCMV) in HFF cells; Not determined | Homo sapiens | 1 | ALA1130554 | cell-based format | Scientific Literature | |
4. | ALA696030 | F | Tested for effective concentration required to inhibit human cytomegalovirus (HCMV) in HFF cells | Homo sapiens | 1 | ALA1130554 | cell-based format | Scientific Literature | |
5. | ALA698434 | F | Tested for the cytotoxicity against hepatitis B virus (HBV) in HepG2.2.15 cells | Homo sapiens | 1 | ALA1130554 | cell-based format | Scientific Literature | |
6. | ALA698435 | F | Tested for the effective concentration required to inhibit HBV in HepG2.2.15 human liver cells | Homo sapiens | 8 | ALA1130554 | cell-based format | Scientific Literature | |
7. | ALA690917 | F | Tested for cytotoxic concentration against hepatitis B virus | Hepatitis B virus | 1 | ALA1130554 | organism-based format | Scientific Literature | |
8. | ALA691886 | F | Tested effective dose against hepatitis B virus in vitro | Hepatitis B virus | 1 | ALA1130554 | organism-based format | Scientific Literature | |
9. | ALA713374 | F | Tested for cytotoxic concentration against influenza virus in MDBK cells | Bos taurus | 1 | ALA1130554 | cell-based format | Scientific Literature | |
10. | ALA713272 | F | Tested for effective concentration required to inhibit of influenza virus in MDBK cells | Bos taurus | 1 | ALA1130554 | cell-based format | Scientific Literature | |
11. | ALA818735 | F | Tested for cytotoxic concentration against herpes simplex virus type 1 (HSV-1) in WI-38 cells | Homo sapiens | 1 | ALA1130554 | cell-based format | Scientific Literature | |
12. | ALA818736 | F | Tested for cytotoxic concentration against varicella zoster virus (VZV) in WI-38 cells | Homo sapiens | 1 | ALA1130554 | cell-based format | Scientific Literature | |
13. | ALA818737 | F | Tested for effective concentration required to inhibit herpes simplex virus type 1 (HSV-1) in WI-38 cells | Homo sapiens | 1 | ALA1130554 | cell-based format | Scientific Literature | |
14. | ALA818738 | F | Tested for effective concentration required to inhibit varicella zoster virus (VZV) in WI-38 cells; 30-60 | Homo sapiens | 1 | ALA1130554 | cell-based format | Scientific Literature | |
15. | ALA904367 | F | Inhibition of HBV replication with RT A200V substitution from Lamivudine refractory patient transfected into HepG2 cells | Hepatitis B virus | 1 | ALA1142075 | organism-based format | Scientific Literature | |
16. | ALA904368 | F | Inhibition of HBV replication with RT A200V substitution and M204I background from Lamivudine refractory patient transfected into HepG2 cells | Hepatitis B virus | 1 | ALA1142075 | organism-based format | Scientific Literature | |
17. | ALA904369 | F | Inhibition of HBV replication with RT A200V substitution and L180M, M204I background from Lamivudine refractory patient transfected into HepG2 cells | Hepatitis B virus | 1 | ALA1142075 | organism-based format | Scientific Literature | |
18. | ALA904370 | F | Inhibition of HBV replication with RT L80V substitution and L180M, M204V background from Lamivudine refractory patient transfected into HepG2 cells | Hepatitis B virus | 1 | ALA1142075 | organism-based format | Scientific Literature | |
19. | ALA904371 | F | Inhibition of HBV replication with RT V27A substitution and L180M, M204V background from Lamivudine refractory patient transfected into HepG2 cells | Hepatitis B virus | 1 | ALA1142075 | organism-based format | Scientific Literature | |
20. | ALA904372 | F | Inhibition of HBV replication with RT I53F substitution and V173F, L180M, M204V background from Lamivudine refractory patient transfected into HepG2 cells | Hepatitis B virus | 1 | ALA1142075 | organism-based format | Scientific Literature |